Diverse companies have made inroads into India’s nutrition industry this summer. On August 24, Paris-based pharmaceutical conglomerate Sanofi Group announced its agreement to purchase the nutraceuticals segment of India’s Universal Medicare Ltd. for US$109 million, according to Reuters.

Earlier this month, on the other side of the world, Osaka-based Kaneka Corporation, chemicals manufacturer and CoQ10 supplier, inked a partnership with Hydride Ion Corporation (HIC) to distribute supplements through Generix Lifesciences, a Delhi-based firm. Generix proffers raw materials to pharmaceutical companies, and has created a new division, Genlife, to market four products from Kaneka and one from HIC in India.